Genomics (NasdaqGS:TXG) is collaborating with PerturbAI, NVIDIA, and the Allen Institute on what is described as the largest ...

The market is projected to surpass $16 billion by 2033, reflecting its rapid transition from research labs into clinical applications such as oncology and prenatal testing. Yet despite this momentum, ...

Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...

“This workflow brings next-generation single-cell multiomics within reach of every lab,” said Suresh Pisharody, CEO of BioSkryb Genomics. “By reducing the need for complex cell sorting methods like ...

Researchers from the Earlham Institute, in collaboration with The Department of Biology at the University of Oxford, ...

PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to ...

LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2020 meeting the ...

Single-cell genomics and gene expression analysis have redefined our understanding of cellular complexity by enabling the dissection of gene activity at an individual cell level. This field leverages ...

Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...

BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME ™ Whole Genome and Transcriptome Single-Cell Core Kit ...